Clinical Trials Directory

Trials / Completed

CompletedNCT03744364

Low-dose Vaginal Misoprostol Versus Vaginal Dinoprostone Insert for Induction of Labor

Low-dose Vaginal Misoprostol Versus Vaginal Dinoprostone Insert for Induction of Labor Beyond 41st Week: a Randomized Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
198 (actual)
Sponsor
Hospital Miguel Servet · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Purpose: To compare the efficacy and safety of low-dose protocol of vaginal misoprostol and vaginal dinoprostone insert for induction of labor in women with post-term pregnancies. Methods: The investigators designed a prospective, randomized, open-labeled, blinded for the end-point evaluators trial including women of at least 41 weeks of gestational age with uncomplicated singleton pregnancies and Bishop score lower than 6. Participants were randomized into dinoprostone or misoprostol groups in a 1:1 ratio. Baseline maternal data and perinatal outcomes were recorded for statistical analysis. Successful vaginal delivery within 24 hours was the primary outcome variable.

Conditions

Interventions

TypeNameDescription
DRUGMisoprostol 25 mcgTo determine efficacy and safety of vaginal 'Misoprostol 25 mcg' every 4 hours with a maximum of 6 doses for induction of labor.
DRUGDinoprostone 10mgTo determine efficacy and safety of 'Dinoprostone 10mg' vaginal insert for induction of labor.

Timeline

Start date
2014-06-01
Primary completion
2017-10-20
Completion
2017-11-01
First posted
2018-11-16
Last updated
2018-11-16

Source: ClinicalTrials.gov record NCT03744364. Inclusion in this directory is not an endorsement.